Significantly, dysregulation of the expression of the MAP2 gene may be associated with tauopathy and cognitive impairment in AD (Fray et al
Increased TMAO levels are caused by lower clearance and increased synthesis as a result of gut dysbiosis, a weakened intestinal barrier, and increased hepatic enzyme activity
Oral administration involves the peptide passing through the digestive system, which can diminish its potency due to enzymatic breakdown
The bioavailability of 25(OH)VD 3 in the blood in response to dietary VD intake varies significantly among individual subjects and is dependent on the status of the VD metabolism genes 14,15,16,17
Free Of: Milk, Eggs, Fish, Shellfish, Tree Nuts, Peanuts, Wheat, Soy, and Sesame
Its progressive dysfunction with agedecline in NAD+, accumulation of ROS, reduction in mitochondrial biogenesisis a central mechanism of aging and degenerative diseases